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Wastewater-based epidemiology is an innovative approach that uses the analysis 
of human excretion products in wastewater to obtain information about exposure to drugs 
in defined population groups. We developed and validated an analytical method for the 
detection and quantification of opioids (morphine, oxycodone, hydrocodone, 
oxymorphone and hydromorphone), and cannabinoids (9-tetrahydrocannabinol, 11-nor-
9-carboxy- tetrahydrocannabinol (THCCOOH) and THCCOOH-glucuronide) in raw-
influent wastewater samples by ultra-high performance liquid chromatography-tandem 
mass spectrometry. Method validation included linearity (5–1 000 ng/L for opioids, 10–1 
000 ng/L for cannabinoids), imprecision (<21.2%), accuracy (83%–131%), matrix effect 
(from –35.1% to –14.7%) and extraction efficiency (25%–84%), limit of detection (1–5 
ng/L) and quantification (5–10 ng/L) and auto-sampler stability (no loss detected). River, 
sewage overflow and wastewater samples were collected in triplicate from different 
locations in New York City and stored at -20 C until analysis. River water samples were 
negative for all the compounds. Water from sewage overflow location tested positive for 
morphine (10.7 ng/L), oxycodone (4.2–23.5 ng/L), oxymorphone (4.8 ng/L) and 
hydromorphone (4.2 ng/L). Wastewater samples tested positive for morphine (133.0–
258.3 ng/L), oxycodone (31.1– 63.6 ng/L), oxymorphone (16.0–56.8 ng/L), 
hydromorphone (6.8–18.0 ng/L), hydrocodone (4.0– 12.8 ng/L) and THCCOOH (168.2–
772.0 ng/L). This method is sensitive and specific for opioids and marijuana 
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Wastewater analysis is becoming the method of choice for determining what drug(s) are 
being used within geographical areas that wastewater treatment plants service 
(Castiglioni, Thomas, Kasprzyk-Hordern, Vandam, & Griffiths, 2014). By observing 
human biomarkers in sewage water, analysts can monitor the consumption of various 
drugs. These findings can then be compared to, and even supplement, traditional 
anonymous surveys. Wastewater epidemiology/toxicology is inexpensive, provides 
virtually real-time data, and is reliable for assessing the extent of drug use in a 
geographical region of interest. Its ability to rapidly determine drug use trends in an area 
can help with the development of targeted public health programs and policy initiatives in 
these specific communities. However, some disadvantages of wastewater analysis include 
uncertainties because of population flow variations (e.g. with tourists, peak travel 
holidays), sewage flow changes, rainfall, and varying inter-individual drug excretion 
rates (Daghir & Markuszewski, 2010; Daughton, 2011). Whereas wastewater analysis is a 
rapidly growing field in Europe (EMCDDA, 2016), data for the evaluation of wastewater 
in the United States (USA) are scarce (Daughton, 2011; Subedi & Kannan, 2015). This 
type of study has never been performed in New York City (NYC), which is the largest 
city in the USA. 
Prescription opioids are used to treat chronic pain, and their use has increased 
dramatically in recent years. This has been strongly associated with increasing rates of 
nonmedical use of prescription opioids in the USA (Paulozzi, Mack, & Hockenberry, 
2014). This situation has led to opioids being the most abused class of prescription drugs 
(Nationwide Trends, 2015). According to statistics from the New York City Health 
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Department, 59 opioid-related deaths occurred in 2000, and this increased to 220 opioid-
related deaths in 2013 (http://www1. nyc.gov/site/doh/health/health-topics/alcohol-and- 
drug-use-data-tables.page). Between 2005 and 2014, the rate of deaths because of 
prescription opioids increased 250% (rate of increase per 100 000 general population). In 
2005, prescription opioids contributed to 29% of the drug overdoses in New York, and 
this figure rose to 43% by 2014 (http://www.osc. 
state.ny.us/press/releases/june16/heroin_and_opioids.pdf). According to the 2014 
National Survey on Drug Use and Health (Center for Behavioral Health Statistics and 
Quality, 2015), 4.3 million people aged 12 or older have reported current nonmedical use 
of prescription pain relievers. 
In the USA, marijuana is the most commonly used illicit drug, with 22.2 million 
marijuana users aged 12 or older that have used the drug in the past month (past-month 
users) (Center for Behavioral Health Statistics and Quality, (2015). This is followed by 
stimulants (1.6 million past-month users), cocaine (1.5 million past-month users) and 
heroin (400,000 past-month users). Based on National Statistics, 44% of adolescents 12 
years and older have used marijuana in their lifetime, which is about the same percentage 
as individuals aged 26 and older. Individuals aged 18 to 25 years old have the highest 
percentage of marijuana users (52%) (https://www.drugabuse.gov/national-survey-drug-
use-health). On July 7 2014, New York became the 23rd state to legalize medical 
marijuana (https://www. health.ny.gov/regulations/medical_marijuana/), allowing 
medical facilities in eight cities to prescribe capsules, liquids, oils, or vaporizable forms 
of cannabis. The effect of marijuana legalization on prevalence of use is still unknown. 
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Several authors have published methods for the determination of licit and illicit 
drugs in wastewater (Baker & Kasprzyk-Hordern, 2011; Berset, Brenneisen, & Mathieu, 
2010; Bijlsma, Sancho, Pitarch, Ibáñez, & Hernández, 2009; Bisceglia, Lynn Roberts, 
Schantz, & Lippa, 2010; Boleda, Galceran, & Ventura, 2007; Castiglioni et al., 2006; 
Chiaia, Banta-Green, & Field, 2008; Fedorova, Randak, Lindberg, & Grabic, 2013; 
González-Mariño, Quintana, Rodríguez, Gonzáez-Díez, & Cela, 2012; Gul, Stamper, 
Godfrey, Gul, & ElSohly, 2016; Heuett, Ramirez, Fernandez, & Gardinali, 2015; 
Hummel, Löffler, Fink, & Ternes, 2006; Mastroianni, Postigo, De Alda, & Barcelo, 
2013; Postigo & Alda, 2008; Senta, Krizman, Ahel, & Terzic, 2013; Vazquez-Roig, 
Andreu, Blasco, & Picó, 2010). However, prescription opioid data are scarce, and 
wastewater samples have never been analyzed for the major cannabis metabolite in 
human urine, 11-nor-9-carboxy-tetrahydrocannabinol-glucuronide (THCCOOH-
glucuronide). The objective of this study was to develop and validate an analytical 
method for the detection of morphine, common prescription opioids (oxycodone, 
oxymorphone, hydrocodone and hydromorphone) and cannabinoids (9-
tetrahydrocannabinol (THC) and its metabolites THCCOOH and THCCOOH-
glucuronide) in wastewater samples. Then, for proof of concept, this method was applied 
to river water, sewage overflow and wastewater samples collected from different 
locations within NYC. 
Materials and methods 
Reagents and materials 
Morphine, oxycodone, hydrocodone, oxymorphone, hydromorphone, 9-
tetrahydrocannabinol (THC) and its metabolites 11-nor-9-carboxy-tetrahydrocannabinol 
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(THCCOOH) and THCCOOH-glucuronide were purchased from Cerilliant (Round Rock, 
TX, USA). The deuterated analogs THC-d3, THCCOOH-d3, THCCOOH-glucuronide-d3, 
morphine-d3, oxycodone-d6, hydrocodone-d6, oxymorphone-d3 and hydromorphone-d6 
were also purchased from Cerilliant. Strata XC 33 mm polymeric strong cation exchange 
cartridges of 3 mL/60 mg for calibrators and 6 mL/200 mg for quality control (QC) and 
authentic wastewater samples were purchased from Phenomenex (Torrance, CA, USA). 
Hydrochloric acid (HCl), ultra-high performance liquid chromatography (UHPLC) grade 
methanol, dichloromethane and ammonium hydroxide was purchased from 
PharmcoAaper (Brookfield, CT, USA). Isopropanol, liquid chromatography mass 
spectrometry grade acetonitrile, and Whatman glass microfiber filters (outside diameter 
4.7 cm, particle retention 1.6 mm, and thickness 0.26 mm) were from Thermo Fisher 
Scientific (Waltham, MA, USA). 
Method Optimization  
To ensure the best method would be implemented for the extraction and analysis of target 
compounds in wastewater samples, mass spectrometry (MS) optimization of each 
compound (precursor and product ions) was performed. After which, multiple extraction 
methods, solid phase extraction cartridges, liquid chromatography columns and 
separation programs/ reconstitution solutions were tested.  
MS optimization of compounds involved injecting 1 or 2 L of individual 
solutions of each compound at either 0.1 or 1 g/mL. The precursor ion and all products 
produced from that precursor ion at various collision energies were manually reviewed. 
Product ions created in the most abundance and with consistency across energies were 
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chosen as quantifier or qualifier, and the respective voltages of the two quadrupoles and 
the collision energy cell was recorded. 
To obtain the best separation among compounds in a short period of time, 
different columns and gradients were attempted. Two types of columns were tested (C-18 
and EVO) to ascertain which would provide the best Gaussian peak shapes and great 
separation. The mobile phase was a mixture of A (0.1% formic acid in water) and B 
(0.1% formic acid in acetonitrile). 
A variety of solid phase extraction (SPE) cartridges were tested with different 
extraction procedures to ascertain which would give the best yield for all compounds of 
interest. SPE cartridges included Oasis HLB, Hypersep Verify Ax, Strata X-B Drug, and 
Strata XC cartridges. Extraction steps (conditioning, loading, washing, drying, and 
eluting) were optimized by using solvent mixtures on the same cartridge type to compare 
yields. Test samples were prepared in either diluted hydrochloric acid or diluted acetic 
acid for the load step. Depending on the cartridge type, washing steps varied from acidic 
to basic with the use of ammonium hydroxide, acetic acid or hydrochloric acid, along 
with methanol and water. The elution step varied as well depending on the cartridge type 
by utilizing a combination of solvents such as ethyl acetate/ isopropanol/ ammonium 
hydroxide, dichloromethane/ isopropanol, dichloromethane/ isopropanol/ ammonium 
hydroxide or methanol/ ammonium hydroxide in different percentages. Elution was also 
tested as a 1-step or 2-step process. 
Instrumentation 
The chromatographic separations were carried out on an UHPLC–tandem mass 
spectrometry (MS/MS) instrument from Shimadzu (Kyoto, Japan). The Nexera UHPLC 
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system consisted of a binary LC-20ADXR high-performance liquid chromatography 
pump, Nexera LC-30AD micro mixer, online degassing unit (DGU-20A3R) and cooled 
autosampler (SIL-20SCHT UFLC). The chromatographic column was a Kinetex C18 (2.1 
mm x 100 mm, 1.7 mm particle size, 100 A pore size) and the guard column was a 
SecurityGuard ULTRA Cartridges C18 (2.1 mm, Phenomenex). Mobile phase A was 
0.1% formic acid in water and mobile phase B was 0.1% formic acid in acetonitrile. The 
following gradient program was used for elution of cannabinoids: held at 40% B for 4 
min, increased to 95% B and held for 1 min, decreased to 40% B in 0.5 min and held at 
40% B for 1.5 min (Figure 1.). The total run time was 7 min and the mobile phase flow 
rate was 0.5 mL/min. The following gradient program was used for elution of opioids: 
held at 2% B for 1 min, increased to 30% B in 3 min, increased to 95% B in 2 min and 
held for 1 min, decreased to 2% B in 0.5 min and held for 2.5 min (Figure 2.). The total 
run time was 10 min and the mobile phase flow rate was 0.3 mL/min. The column oven 
was operated at 40 C for both gradients. The injection volume was 50 µL for each set of 
compounds.  
The mass spectrometer was a triple quadrupole LC- MS 8030 from Shimadzu 
equipped with a dual ionization source (atmospheric pressure chemical ionization and 
electrospray ionization). The nebulizing gas flow was set to 2 L/min, the desolvation line 
was at 250 C, the heating block was at 400 C and the drying gas flow was at 15 L/min. 
The dual ionization source corona needle voltage and interface voltage were both set to 
4.5 kV. Two multiple reaction monitoring (MRM) transitions were monitored for each 
compound (Table 1), with one used as a quantifier and the other as a qualifier.  
Sample preparation 
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An aliquot (100 mL) of each wastewater sample was measured using a graduated 
cylinder and placed in a beaker, spiked with 50 µL of internal standard mixture (0.1 
g/mL), and filtered through a glass microfiber filter. Then, 0.5 mL of HCl was added 
immediately to acidify the solution to maximize retention onto mixed- mode cartridges. 
Figure 1. Liquid chromatography gradient for cannabinoids. Mobile phase A was 0.1% formic acid in 
water and B 0.1% formic acid in acetonitrile. 
 
 
Figure 2. Liquid chromatography gradient for opioids. Mobile phase A was 0.1% formic acid in water 
and B 0.1% formic acid in acetonitrile. 
  
Solid phase extraction 
Strata XC 6 mL/200 mg cartridges were conditioned with 6 mL of methanol, 6 mL of 


















































wastewater was manually loaded 6 mL at a time (17 times) onto a cartridge with a small 
vacuum (<34 473 Pa). The cartridges were washed with 4 mL of UHP water and 4 mL of 
0.1% HCl, and then dried under vacuum for 15 min. Finally, 8 mL of elution solvent 
(Vdichloromethane:Visopropanol: Vammonium hydroxide  78:20:2) was added. A vacuum was applied 
to retrieve all the solvent, and the eluate was split in half. The opioid samples were 
labelled set 1, and the cannabinoid samples were labelled set 2. Each set was evaporated 
to dryness under a steady stream of N2 in a Biotage TurboVap (Uppsala, Sweden) at 40 
C. The opioid samples (set 1) were reconstituted in 200 L of UHP water, and the 
cannabinoid samples (set 2) were reconstituted in 200 L of a mixture (VA:VB = 60:40) 
of mobile phases A (0.1% formic acid in water) and B (0.1% formic acid in acetonitrile).  
Calibrators, quality controls and internal standards 
An internal standard working solution was prepared by diluting each ampoule with pure 
methanol and combining all analogues to a final concentration of 0.1 g/mL in methanol. 
Stock solutions of each compound were prepared in pure methanol (at either 10 or 100 
g/mL) and combined to a stock concentration of 1 g/mL. This solution was then 
serially diluted to concentrations of 0.001, 0.01, 0.1, and 1 g/mL and used to prepare 
quality control and calibration curve samples at concentrations of 0.5, 1, 3, 5, 10, 50, 100, 
500 and 1 000 ng/L. 
To reduce the cost and time of this process, calibrators were prepared in 3 mL of UHP 
water and spiked with the corresponding calibration working solution to match 
concentrations of 5 to 1 000 ng/L in a 100 mL sample. For the calibration curve, clean 
test tubes were prepared by adding 3 mL of UHP water, 50 µL of internal standard 
mixture (0.1 g/mL), and the following volumes of the respective calibrator working 
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solution: 50 and 100 L of the 0.01 g/mL solution for 5 and 10 ng/L calibrators, 50 and 
100 L of the 0.1 g/mL solution for 50 and 100 ng/L calibrators, and 50 and 100 L of 
the 1 g/mL solution for 500 and 1 000 ng/L calibrators. Lastly, 15 L of HCl (0.5%) 
was added before vortex mixing and SPE. Strata XC 3 mL/60 mg cartridges were 
conditioned with 3 mL of methanol, followed by 3 mL of UHP water and 3 mL of 0.1% 
HCl. The acidified calibrator was loaded onto the mixed-mode cartridge. Cartridges were 
washed with 2 mL of UHP water and 2 mL of 0.1% HCl, and then dried under vacuum 
for 15 min. Sample elution was performed with 4 mL of a 
dichloromethane/isopropanol/ammonium hydroxide mixture (Vdichloromethane:Visopropanol: 
Vammonium hydroxide  78:20:2). 
 
Table 1. MRM transitions, retention time (RT), and precursor ion for each analyte of interest.  













Morphine  3.14 286 165 -40 181 -33 
Morphine-d3  3.13 289 164 -44 153 -43 
Hydromorphone  3.44 286 184 -33 157 -43 
Hydromorphone-d6  3.42 292 185 -33 157 -49 
Oxymorphone  3.29 302 226 -32 242 -28 
Oxymorphone-d3 3.29 304 201 -45 230 -31 
Oxycodone  3.98 316 256 -26 212 -46 
Oxycodone-d6 3.97 322 247 -31 262 -29 
Hydrocodone  4.10 300 199 -31 170 -40 
Hydrocodone-d6 4.08 306 202 -36 174 -44 
THC  4.01 315 193 -23 122 -38 
THC-d3 4.00 318 195 -27 122 -39 
THCCOOH  2.87 345 299 -21 192 -28 




1.98 521 345 -15 326 -18 
THCCOOH- 
Glucunoride-d3 
1.94 524 348 -15 330 -21 
1Collision energy for Quantifier production 
2Collision energy for Qualifier production 
 
The eluate was split in half. The samples were labelled as set 1 for opioids and set 2 for 
cannabinoids. Each set was evaporated to dryness under a steady stream of N2 in a 
Biotage TurboVap at 40 C. Opioid samples (set 1) were reconstituted in 200 L of UHP 
water, and cannabinoids samples (set 2) were reconstituted in 200 L of a mixture 
(VA:VB  60:40) of mobile phases A (0.1% formic acid in water) and B (0.1% formic 
acid in acetonitrile). 
QC samples were prepared at 10 and 100 ng/L by spiking 100 mL of UHP water with the 
required amount of the working solution and 50 L of the internal standard mixture. 
These samples were then filtered, and 0.5 mL of HCl was added before SPE. 
Authentic sample collection 
For proof of concept, 33 samples were collected from river water (22 samples), sewage 
overflow (6 samples) and raw influent from wastewater treatment plants (5 samples) in 
NYC. River samples were collected from the Hudson and East Rivers in the Bronx, 
Manhattan, Queens and Roosevelt Island. Sewage overflow samples were collected from 
Newtown Creek (Brooklyn), and wastewater samples were collected from the Tallman 
and Jamaica wastewater treatment plants in Queens. Samples were collected for 1–3 days 
before and after national holidays (Independence Day, July 4 2015; Labor Day, 
September 7 2015; New Year’s Day, January 1 2016) and on March 25th and 30th 2016. 
The samples were collected at one time point on each of these days (between 7 and 11 
am) in 200 mL Nalgene Certified Wide-Mouth Amber high-density polyurethane 
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bottles (Thermo Fisher Scientific). To prevent degradation of the target drugs, the 
samples were stored in a freezer at –20  C until required for analysis.  
Validation parameters 
The method was validated using various procedures outlined by the Scientific Working 
Group for Forensic Toxicology guidelines (“Scientific working group for forensic 
toxicology (SWGTOX) standard practices for method validation in forensic toxicology,” 
2013) for the linearity, limit of detection (LOD), limit of quantification (LOQ), 
interferences (specificity), autosampler stability, imprecision, accuracy, carryover, 
extraction efficiency, process efficiency and matrix effect. 
Linearity was determined over five different days by least-squares regression and 
different weighting factors (none, 1/x and 1/x2) were evaluated. The linearity was 
acceptable if the coefficient of determination (R2) was  0.99 and the residuals were 
within 20%. The LOD and the LOQ were evaluated with decreasing analyte 
concentrations in spiked samples from three different sources. The LOD was the lowest 
concentration with acceptable chromatography, a signal-to-noise ratio > 3, the presence 
of all product ions, the correct ion ratio (within ±20% of the average of the calibrators) 
and a suitable retention time (within ±0.2 min of the retention time of the calibrators). 
The LOQ satisfied the LOD criteria and was quantified within ±20% imprecision and 
80%–120% accuracy. 
Interferences from matrix components were evaluated by analyzing river (n =22) 
and wastewater (n = 4) samples negative for the compounds of interest, after spiking with 
the internal standard solution. Interferences were considered insignificant if the analytes 
of interest were not detected in these samples. Method specificity was demonstrated by 
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analyzing high concentrations (1,000 ng/L) of potentially interfering drugs. The 
following compounds and their metabolites were examined: opioids (morphine-3-
glucuronide, morphine-6-glucuronide, hydromorphone-3-glucuronide, oxymorphone-3-
glucuronide, oxymorphone-6-glucuronide and 6-acetylmorphine), cannabinoids (11-
hydroxy-THC, cannabinol, and cannabidiol) and common drugs of abuse (cocaine, 
benzoylecgonine, amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine, 
3,4-methylenedioxymethamphetamine and methadone). Sufficient specificity was 
achieved if the analytes of interest were below the LOD. 
To determine carryover, blank samples spiked with the internal standard (negative 
calibrator) were injected immediately after samples spiked at 2,000 ng/L (twice the 
highest calibrator concentration). The carryover was considered negligible if the 
measured concentration was less than the LOD. Before SPE, the 2,000 ng/L samples 
were prepared using 3 mL of UHP water and spiking it with 50 L of internal standard, 
200 L of the 1 g/mL calibrator solution and 15 L of HCl. 
Inter- and intra-day QC samples at 10 ng/L and 100 ng/L were prepared with 100 
mL of UHP water spiked with 100 L of the 0.01 g/mL solution (for 10 ng/L 
concentration) or the 0.1 g/mL solution (for 100 ng/L concentration). The imprecision 
and accuracy were determined at these two concentrations with four repeat analyses in 
one day (intra-day n = 4) and over five days (inter-day n = 5). The imprecision was 
determined using the coefficient of variation of the measured values and expected to be 
less than 20%. The intra- and inter-day imprecision were calculated as the standard 
deviation of the QC concentrations x 100/ mean QC concentrations. The accuracy was 
calculated as a percentage of the target concentration, and was required to be within 
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80%–120%. The intra- and inter- day accuracy was calculated as the mean QC 
concentrations x 100/QC target concentration. 
Autosampler stability was evaluated by reinjecting four QC samples after 24 h in 
the autosampler at 10 °C. The QC samples were prepared at 10 ng/L using 100 mL of 
UHP water and 100 L of 0.01 g/mL calibrator working solution. The concentrations 
within ±20% of the initial concentration were considered acceptable.  
To evaluate the matrix effect, extraction efficiency and process efficiency, three sets of 
samples were prepared in duplicate at the same concentration (10 ng/L). Set 1 contained 
neat samples prepared by adding 2 mL of elution solvent, 50 L of internal standard, and 
100 L of the 0.01 g/mL solution to a clean test tube. This sample was then split, 
evaporated to dryness and reconstituted in the appropriate opioid or cannabis mobile 
phase for LC-MSMS separation and analysis. Set 2 contained QC samples spiked at 10 
ng/L with the internal standard and submitted to the same sample preparation and 
extraction steps as normal samples. Set 3 contained QC samples spiked at 10 ng/L and 
with the internal standard post-extraction. The samples were from four different sources, 
one set prepared with UHP water and three sets using authentic wastewater samples that 
tested negative for the target drugs. The peak areas for Set 1 and 3 were compared to 
determine if there were any matrix effects. The peak areas for the Set 2 and 3 samples 
were compared to assess the extraction efficiency, and those for Set 1 and Set 2 were 
used to assess the process efficiency.  
Identification criteria  
The identification criteria included retention time within ±0.2 min of the calibrators 
retention time, the presence of two product ions (quantitative and qualitative) and an ion 
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ratio within ±20% of the average of the calibrators. 





The LOQ and LOD for all opioids were 5 and 1 ng/L, respectively, and the linear range 
was 5–1,000 ng/L. For the cannabinoids, the LOQ, LOD and linear range were 10, 5 and 
10–1,000 ng/L, respectively. Acceptable linearity for opioids and cannabinoids (R2 ≥ 
0.99 and residuals within ±20%) were achieved with 1/x2 weighting. No endogenous or 
exogenous interferences were detected. 
For opioids, the intra- and inter-day imprecision were 3.3% to 14.1%, 
respectively, and the accuracy was 93.3%–131.0%. For cannabinoids, the intra and inter- 
day imprecision were 4.1% to 21.2%, respectively, and the accuracy was 83.0% to 
119.3%. For opioids, the extraction efficiency range was 75.0%–84.0%, and the process 
efficiency range from 63.1% to 73.3%. For cannabinoids, the extraction efficiency range 
was 25.4%– 66.5% and the process efficiency range was 22.7%– 62.7%. For opioids, the 
Compound Imprecision (%) Accuracy (%) 
  Inter-day (n=5) Intra-day (n=4) Inter-day (n=5) Intra-day (n=4) 
  10 (ng/L) 100 (ng/L) 10 (ng/L) 100 (ng/L) 10 (ng/L) 100 (ng/L) 10 (ng/L) 100 (ng/L) 
Morphine 11.4 6.2 5.6 3.4 93.3 94.7 116.0 110.9 
Oxymorphone 10.8 3.9 4.9 3.3 106.5 106.6 126.5 109.1 
Hydromorphone 14.1 3.3 12.9 4.4 98.3 103.3 119.5 121.1 
Oxycodone 8.9 7.6 10.9 5.0 98.3 101.1 110.0 102.0 
Hydrocodone 10.0 8.8 6.1 4.8 107.5 103.7 131.0 127.2 
THC 9.7 9.0 21.2 7.9 102.8 98.8 110.3 106.6 
THCCOOH 8.0 6.1 5.0 7.3 97.3 105.6 119.3 103.4 
THCCOOH-
Glucuronide 
6.0 10.3 4.1 5.5 95.0 98.9 83.0 102.3 
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matrix effects range was –35.1% to –7.6% (ion suppression), with a coefficient of 
variation of 28.3% (n = 4). For cannabinoids, the matrix effects range was –14.7% to –
5.8%, with a coefficient of variation of 13.9% (n = 4). These results are summarized in 
Tables 2 and 3. 
Carryover was assessed by injecting a blank after injection of a sample prepared 
at 2,000 ng/L (twice the concentration of the highest calibrator). The results for all target 
compounds for the blank were below LOD. Autosampler stability was assessed by 
injecting the same samples fresh and after 24 h in the autosampler at 10 °C. The mean 
concentrations from these injections were compared to determine the percentage 
difference. The concentrations of all target compounds were within the accepted 20%, 
except for oxymorphone (–21.3%). 














Morphine 79.0 73.3 -7.6 9.9 
Oxymorphone 84.0 63.1 -24.5 8.7 
Hydromorphone 75.0 48.8 -35.1 28.3 
Oxycodone 82.0 63.5 -23.1 21.7 
Hydrocodone 84.0 72.6 -13.8 16.1 
THC 25.4 22.7 -10.6 13.9 
THCCOOH 66.5 62.7 -5.8 11.6 
THCCOOH-
Glucuronide 
53.1 45.3 -14.7 9.5 
 
Application to authentic samples 
Samples from the East and Hudson rivers tested negative for morphine, prescription 
opioids and cannabis. Samples from sewage overflows (Newtown Creek, Brooklyn) 
tested positive for morphine (10.7 ng/L), oxycodone (4.2–23.5 ng/L), oxymorphone (4.8 
ng/L) and hydromorphone (4.2 ng/L). Wastewater samples from the Tallman and Jamaica 
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plants in Queens tested positive for morphine (133.0–258.3 ng/L), oxycodone (31.1–63.6 
ng/L), oxymorphone (16.0–56.8 ng/L), hydromorphone (6.8–18.0 ng/L), hydrocodone 
(4.0– 12.8 ng/L) and THCCOOH (168.2–772.0 ng/L) (Table 4). Figure 3 shows a 
chromatogram of an authentic wastewater sample that tested positive for opioids and 
cannabinoids.  
Table 4. Results from  wastewater plants (Tallman and Jamaica, New York City, NY) collected at one 
time point 1-3 days before and after national holidays (Independence Day, July 4, 2015; Labor Day, 





Morphine 133.0 – 258.0 5 
Hydrocodone 4.0 – 12.8 4 
Oxycodone 31.1 – 63.6  5 
Oxymorphone 16.0 – 56.8 5 
Hydromorphone 6.8 – 10.0 5 
THCCOOH 168.2 – 641.4 5 
 
Discussion 
We developed and validated a method for the detection of morphine, oxymorphone, 
oxycodone, hydromorphone, hydrocodone, THC and its metabolites THCCOOH and 
THCOOH-glucuronide in wastewater samples. Numerous methods for the analysis of 
licit and illicit drugs in wastewater samples have been published (Baker & Kasprzyk-
Hordern, 2011; Berset et al., 2010; Bijlsma et al., 2009; Bisceglia et al., 2010; Boleda et 
al., 2007; Castiglioni et al., 2006; Chiaia et al., 2008; Fedorova et al., 2013; González-
Mariño et al., 2012; Gul et al., 2016; Heuett et al., 2015; Hummel et al., 2006; 
Mastroianni et al., 2013; Postigo & Alda, 2008; Senta et al., 2013; Vazquez-Roig et al., 
2010). These analytical methods allow for the quantification of opiates and prescription 
opioids (Baker & Kasprzyk-Hordern, 2011; Bisceglia et al., 2010; Chiaia et al., 2008; Gul 
et al., 2016; Hummel et al., 2006), cannabis (Bijlsma et al., 2009; Fedorova et al., 2013) 
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or both classes of compounds, opiates and cannabis (Baker & Kasprzyk-Hordern, 2011; 
Berset et al., 2010; Castiglioni et al., 2006; Fedorova et al., 2013; González-Mariño et al., 
2012; Heuett et al., 2015; Mastroianni et al., 2013; Postigo & Alda, 2008; Senta et al., 
2013). In the case of opiates, most of the methods can only detect morphine (Baker & 
Kasprzyk-Hordern, 2011; Berset et al., 2010; Bisceglia et al., 2010; Boleda et al., 2007; 
Castiglioni et al., 2006; González-Mariño et al., 2012; Gul et al., 2016; Heuett et al., 
2015; Hummel et al., 2006; Mastroianni et al., 2013; Postigo & Alda, 2008; Senta et al., 
2013; Vazquez-Roig et al., 2010), although some methods are suitable for prescription 
opioids such as oxycodone, oxymorphone, hydrocodone and hydromorphone (Baker & 
Kasprzyk-Hordern, 2011; Bisceglia et al., 2010; Chiaia et al., 2008; Fedorova et al., 
2013; Gul et al., 2016; Heuett et al., 2015; Hummel et al., 2006). With regard to cannabis, 
most methods have been developed for THCCOOH (Berset et al., 2010; Bijlsma et al., 
2009; Castiglioni et al., 2006; Fedorova et al., 2013; Senta et al., 2013) or for THC or 
THC and THCCOOH (Boleda et al., 2007; González-Mariño et al., 2012; Heuett et al., 
2015; Mastroianni et al., 2013; Postigo & Alda, 2008; Vazquez-Roig et al., 2010). There 
is no data available for THCCOOH-glucuronide in wastewater samples, even though this 
compound is the predominant THC metabolite in human urine (Desrosiers et al., 2014). 
This may be because glucuronides are normally hydrolyzed in wastewater (Ternes, 
1998), resulting in higher concentrations of the free compound. However, recent 
publications have reported high concentrations of glucuronides in wastewater samples 
(Wang & Gardinali, 2014; Zonja, Perez, & Barcelo, 2016). These results highlight the 
need for a method for detection of glucuronides in wastewater. 
 18 
Currently, the most commonly used instrument for wastewater analysis is LC-
MSMS. However, gas chromatography-mass spectrometry has been used as well 
(González-Mariño, Quintana, Rodríguez, & Cela, 2010). In the present method, all 
compounds were ionized in positive mode using dual ionization sources (atmospheric 
pressure chemical/electrospray ionization), despite other authors finding better sensitivity 
for cannabinoids in negative ionization mode (electrospray ionization) (Castiglioni et al., 
2006; González-Mariño et al., 2012; Postigo & Alda, 2008; Senta et al., 2013). The 
sensitivity of our method (LOD 1–5 ng/L and LOQ 5–10 ng/L in 100 mL of wastewater) 
was within the range of methods in previous publications (Berset et al., 2010; Bisceglia et 
al., 2010; Fedorova et al., 2013; Mastroianni et al., 2013). Earlier studies have reported 
LOQs for the compounds of interest as low as 0.48 ng/L (Zuccato et al., 2008) and as 
high as 100 ng/L (Berset et al., 2010) for wastewater volumes between 15 mL (Gul et al., 
2016) and 250 mL (Boleda et al., 2007). Sample preparation usually involves filtration 
and SPE with a reversed-phase (Oasis HLB, Waters Corp., Milford, MA, USA) or cation 
exchange (Oasis MCX, Waters Corp.) cartridges. 
During method validation, matrix effect experiments were carried out using four 
different matrices instead of six (“Scientific working group for forensic toxicology 
(SWGTOX) standard practices for method validation in forensic toxicology,” 2013). This 
limitation was because it was difficult to obtain wastewater samples that were negative 
for the compounds of interest. Another limitation of the present method was the intra-day 
accuracy above the established criteria for three opioids. Although oxymorphone’s low 
QC, hydromorphone’s high QC and hydrocodone’s low and high QC gave an intra-day 
accuracy >120% (121.1% to 131%), the rest of the validation parameters were within the 
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established range (“Scientific working group for forensic toxicology (SWGTOX) 
standard practices for method validation in forensic toxicology,” 2013). 
 
Figure 3. Multiple reaction monitoring chromatograms of an authentic wastewater sample from 
Tallman Island Wastewater Treatment Plant (Queens, NYC) showing positive results for THCCOOH 
(184.1 ng/L), morphine (181.9 ng/L), hydromorphone (10.0 ng/L), oxymorphone (56.8 ng/L), 
oxycodone (63.3 ng/L) and hydrocodone (10.3 ng/L). 
 
As a proof of concept, we were able to detect THCCOOH, morphine and 
prescription opiates in water samples from sewage overflow locations and wastewater 
treatment plants. The concentrations of morphine (10.7– 258.3 ng/L), oxycodone (4.2–
63.6 ng/L), oxymorphone (4.8–56.8 ng/L), hydromorphone (4.2–18.0 ng/L), hydrocodone 
(4.0–12.8 ng/L) and THCCOOH (168.2–772.0 ng/L) were similar to those found in 
previous studies (Baker & Kasprzyk-Hordern, 2011; Fedorova et al., 2013; Gul et al., 
2016; “Scientific working group for forensic toxicology (SWGTOX) standard practices 
for method validation in forensic toxicology,” 2013; Wang & Gardinali, 2014). THC and 
THCCOOH-glucuronide were not detected in any of the analyzed samples. Previously, 
THC was detected in wastewater samples (Boleda et al., 2007), but there are no reports of 
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the detection of THCCOOH-glucuronide. Continued research is required to investigate 
the importance of monitoring THCCOOH-glucuronide’s in these types of samples, and to 




We developed and validated an analytical method for the extraction, detection, and 
quantification of morphine, common prescription opioids (oxycodone, oxymorphone, 
hydrocodone and hydromorphone), and THC, THCCOOH and THCCOOH-glucuronide 
in wastewater samples. This technique was sensitive (LOD 1–5 ng/L and LOQ 5–10 ng/L 
in 100 mL of sample) and specific. This is the first report of testing for THCCOOH-
glucuronide in wastewater samples. As a proof of concept, we were able to detect 
THCCOOH, morphine, and prescription opioids in samples from sewage overflow 
locations and wastewater plants throughout NYC. 
 
This Thesis has been published in Forensic Sciences Research  
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